Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

Gynecology Devices Market Size, $25.13Bn by 2028, 10.7% CAGR Driven by Gynecological Diseases: The Insight Partners

Published

on

New York, May 25, 2022 (GLOBE NEWSWIRE) — The Insight Partners published latest research study on “Gynecology Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product (Surgical Devices, Hand Instruments, and Diagnostic Imaging System) and End User (Hospitals, Diagnostic Centers, Clinics, and Others)”, the global gynecology devices market growth is driven by the rising number of gynecological diseases and the increasing number of advanced medical devices used for women. However, the limited access to contraception and stringent regulatory approval procedures hamper the market growth.

The Sample Pages Showcases Content Structure and Nature of Information Included in This Research Study Which Presents A Qualitative and Quantitative Analysis: https://www.theinsightpartners.com/sample/TIPHE100001241/

Report Coverage Details
Market Size Value in US$ 13.65 Billion in 2022
Market Size Value by US$ 25.13 Billion by 2028
Growth rate CAGR of 10.7% from 2022 to 2028
Forecast Period 2022-2028
Base Year 2022
No. of Pages 334
No. Tables 301
No. of Charts & Figures 104
Historical data available Yes
Segments covered Product, and End User
Regional scope North America; Europe; Asia Pacific; Latin America; MEA
Country scope US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Gynecology Devices Market: Competitive Landscape and Key Developments
Companies operating in the gynecology devices market implement various organic strategies, such as product launch and product development, to propel the market growth. Several companies are implementing numerous inorganic strategies, such as partnerships and mergers and acquisitions.

Schedule A Pre-Sale Discussion with The Author Team in A Slot That You Prefer to Address Queries on Scope of The Study, Customization, Introduction to Research Methodology, Assistance on Technologies and Market Definitions: https://www.theinsightpartners.com/inquiry/TIPHE100001241/

In September 2021, Ethicon launched industry’s first powered circular stapler for colorectal, gynecological, gastric, and thoracic surgery. It helps address a serious complication associated with colorectal and gastric surgery. The Echelon Circular Powered Stapler reduces leaks by 61% at the staple line, compared to Medtronic’s DST Series Eea Stapler.

In May 2021, Hologic Inc. acquired Biotheranostics, a developer of two highly differentiated molecular diagnostic tests for breast and metastatic cancers – Breast Cancer Index (BCI) and CancerTYPE ID (CTID). Breast Cancer Index predicts which early-stage hormone receptor positive (HR+) breast cancer patients are likely to benefit from extended endocrine therapy and is included in clinical practice guidelines from prominent organizations including the National Comprehensive Cancer Network (NCCN) and the American Society for Clinical Oncology (ASCO).

In September 2020, GE Healthcare unveiled Voluson SWIFT, an AI-enhanced women’s health ultrasound with industry-first auto recognition tools to help improve efficiency. Voluson SWIFT redefines the ultrasound experience for women’s health practitioners by integrating intelligent features that can reduce patient scanning time by as much as 45% and automate exam measurements resulting in significant time savings for users.

Click Here to Avail Lucrative DISCOUNTS on Our Latest Research Reports. We Offer Student, Enterprise, and Special Periodic Discounts to Our Clientele. Please Fill the Form to Know DISCOUNTED PRICE

Global Gynecology Devices Market: Key Insights – Future Trends
Artificial intelligence (AI) will be growing exponentially in various fields, such as gynecology. For instance, in a report by Norwitz et al., an AI software was created to predict prognosis in patients with ovarian cancer more precisely than current methods and predict the effective treatment per each patient diagnosis. Researchers at Brigham and Women’s Hospital and Dana-Farber Cancer Institute have been using AI to change large amounts of micro ribonucleic acid (RNA) data to develop models that can potentially diagnose early ovarian cancer. AI can improve patient outcomes, reduce healthcare costs, and decrease operative time that reduces operative complications using augmented reality, and decrease the workload for clinicians.

In addition, robotics is one of the examples of computer systems assisting in surgery. Incorporating robotics by trained gynecologists is boosting the demand for various surgical instruments. Cancer and other gynecologic conditions can be successfully treated with the innovative robotic technology. Moreover, medical device makers are leaning on leveraging the strength of robotics surgeries to expand their profit. Thus, the rapidly increasing traction of automation technologies, such as robotics, in the treatment of gynecological disorders is expected to boost the growth of the gynecology devices market.

In North America, the US holds a significant share of the gynecology devices market. The market growth in the US is primarily driven by increasing demand for gynecological surgeries, rising prevalence of reproductive disorders among women, and growing technological advancements in gynecology devices. Cancer is one of the major health issues among the women in the US. As per the Centers for Disease Control and Prevention (CDC), breast, colorectal, endometrial, lung, cervical, skin and ovarian cancers are the most common cancers affecting women, and more than 270,000 women die due to cancer.

Have A 15-Minute-Long Discussion with The Lead Research Analyst and Author of The Report in A Time Slot Decided by You. You Will Be Briefed About the Contents of The Report and Queries Regarding the Scope of The Document Will Be Addressed as Well: https://www.theinsightpartners.com/speak-to-analyst/TIPHE100001241

As per the American Cancer Society, in 2019, about 1,762,450 new cancer cases were diagnosed in the US, and an estimated 65,950 people will be diagnosed with endometrial cancer in 2022. Uterine cancer is the fourth most common cancer for women in the country. Additionally, an estimated 13,800 people were diagnosed with cervical cancer across the country in 2020. Thus, the rising number of gynecological cancers requires early diagnosis and surgical procedures to be performed, which would favor the growth of the gynecology devices market during forecast period.

Gynecology Devices Market: Segmental Overview
Based on end user, the gynecology devices market is segmented into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest market share in 2022. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period. Hospitals are the largest entities that have all facilities. In hospitals, all the equipment and instruments required for ECG, MRI, CT scan, and X-ray are available.

Due to the development in the healthcare facilities, hospitals are upgraded with the modernized equipment and are installed with the digital pathology and artificial intelligence. These technologies assist in communicating among inter departments and allow to share data across the domain. Hospitals are associated with various doctors, specialist doctors, and other professionals that provide better healthcare services. All the gynecological diseases can be treated in the hospitals, and the better nursing services are being provided by the staffs. Therefore, owing to all the above-mentioned factors, the gynecology devices market for the hospital segment is likely to grow in the coming years.

Immediate Delivery of Our Off-The-Shelf Reports and Latest Research Studies, Through Flexible and Convenient Payment Methods: https://www.theinsightpartners.com/buy/TIPHE100001241/

Browse Adjoining Reports:
Gynecology Lasers Market Forecast to 2028 – Covid-19 Impact and Global Analysis – by Product type (CO2 Laser, KTP-ARGON Lasers, Nd:YAG Lasers); Basis of application (Colposcopy, Laparoscopy, Hysteroscopy); End user (Hospital, Specialized clinics, Ambulatory surgical centers, Medical centers) and Geography

Surgical Robotics Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Component ( Accessories, Services ); Surgery Type ( Gynecology surgery, Urology surgery, Neurosurgery, Orthopedic surgery, General surgery, Other surgeries )

Hysterometers Market Forecast to 2028 – Covid-19 Impact and Global Analysis – by Type (Disposable, Reusable); End User (Hospitals, Gynecology Clinics, Other End Users) and Geography

Therapeutic Ultrasound Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Technology (High Intensity Focused Ultrasound, Extracorporeal Shockwave Lithotripsy); Application (Cancer, Gynecology and Obstetrics, Cardiovascular Disorders, Urinary Disorders, Others); End-User (Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Others) and Geography

Surgical Tables and Lights Market Forecast to 2028 – Covid-19 Impact and Global Analysis – By Product (Surgical Tables (Gynecology Examination Tables, Operating Tables, Others), Surgical Lights (Halogen, LED), By Application (Private, Public) and Geography

Bladder Scanners Market Forecast to 2028 – Covid-19 Impact and Global Analysis – by Product (Bench top bladder scanners, Portable bladder scanners, Handheld bladder scanners); Application (Urology, Obstetrics-Gynecology and Surgery); End User (Hospitals, Clinic & Surgical centers, Ambulatory care centers and Diagnostic Centers), and Geography

Infant Radiant Warmer Market Forecast to 2027 – Covid-19 Impact and Global Analysis by Product Type (Standard Infant Radiant Warmer, and Mobile Infant Radiant Warmer); End-User (Hospitals, Gynecology Clinics, Baby Care Centers, and Others); and Geography

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/gynecological-devices-market

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Published

on

xtalpi-unveils-xtalgazer:-a-comprehensive-ai-driven-polymorph-selection-platform

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html

Continue Reading

Artificial Intelligence

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading

Artificial Intelligence

Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform

Published

on

trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extrica.ai-–-the-data-to-ai-platform

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.

Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html

Continue Reading

Trending